SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

Share Price is delayed by 15 minutes
Get Live Data
95.00    3.15 (3.43%)
Bid:
95.05
Ask:
95.60
Spread: 0.55 (0.579%)
Market Cap: £375.27m
IBST Live PriceLast checked at - London Stock Exchange

Intraday Ibstock Share Chart

Trading Update

17 Jan 2019 07:00

RNS Number : 3072N
Ibstock PLC
17 January 2019
Ā 

Ā 

Ibstock Plc

Trading Update

Ibstock plc ('Ibstock' or the 'Group'), a leading UK manufacturer of clay bricks and concrete products, today issues a trading update for the year ended 31 December 2018.

The Group has continued to trade as anticipated and adjusted EBITDA for the year is expected to be in line with expectations.

On 23 November 2018, the Group disposed of Glen-Gery, its US brick manufacturing operation. The trading results of this business will be reported as discontinued operations in the full year results for 2018, and therefore excluded from adjusted EBITDA.

Revenues from our UK clay and concrete products were up 8% for the full year compared to 2017, reflecting both price and volume growth, primarily in our clay brick business. We expect to report low single digit growth in adjusted EBITDA for the UK business, which is in line with expectations.

The enhanced maintenance programme in the Group's UK brick business continues to progress well.

As previously announced, we also expect to report £9.5 million of profit on disposal of surplus property during the year. This amount is excluded from the adjusted EBITDA guidance noted above.

As at 31 December 2018, net debt reduced significantly compared to the prior year due to strong underlying cash generation, as well as receipt of the proceeds from the disposal of Glen-Gery and surplus properties throughout the year. As a result, we expect to report net debt to adjusted EBITDA below 0.5x at 31 December 2018, on a continuing basis.

Despite ongoing political and economic uncertainty, we enter 2019 well positioned and with a strong balance sheet. We continue to assess investment options in the UK as we look to deliver long term growth.

The Group will announce its preliminary results for the year ended 31 December 2018 and provide a further update on its strategy on 5 March 2019.

Enquiries to:

Ā 

Ibstock plc

via Citigate Dewe Rogerson

Joe Hudson, CEO

Ā 

Kevin Sims, CFO

Ā 

Citigate Dewe Rogerson

0207 638 9571

Kevin Smith

Ā 

Nick Hayns

Ā 

Ā 

Ā 

About Ibstock Plc

Ibstock plc is a leading manufacturer of clay bricks and a diversified range of clay and concrete products, from its operations in the United Kingdom. Its principal products are clay bricks, brick components, concrete roof tiles, concrete substitutes for stone masonry, concrete fencing and pre-stressed concrete products.

The Group's primary UK businesses are:

-

Ibstock Brick: The leading manufacturer by volume of clay bricks sold in the United Kingdom. With 19 manufacturing sites Ibstock Brick has the largest brick production capacity in the United Kingdom. It operates a network of 23 active quarries which are generally located close to its manufacturing plants. Ibstock Brick has recently commissioned a new soft mud brick manufacturing plant in Leicestershire that added approximately 100 million bricks (c13%) to its brick production capacity per annum.

Ā 

Ā 

-

Supreme: A leading manufacturer of concrete fencing products, concrete lintels and general concrete building products, with seven manufacturing plants in the United Kingdom.

Ā 

Ā 

-

Forticrete: A leading manufacturer of concrete substitutes for natural stone walling, dressings and concrete roof tiles, with seven manufacturing plants in the United Kingdom.

Ā 

Forward-looking statements

This announcement contains "forward-looking statements". These forward-looking statements include all matters that are not historical facts and include statements regarding the intentions, beliefs or current expectations of the directors. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are difficult to predict and outside of the Group's ability to control. Forward-looking statements are not guarantees of future performance and the actual results of the Group's operations. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Group undertakes no obligation to update or revise publicly any forward-looking statements.

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
TSTQQLFFKFFZBBE
Date   Source Headline
22nd May 20269:00 amRNSHolding(s) in Company
21st May 20261:51 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Trading Update
14th May 202611:00 amRNSHolding(s) in Company
13th May 20263:55 pmRNSHolding(s) in Company
13th May 20263:39 pmRNSHolding(s) in Company
1st May 20268:26 amRNSTotal Voting Rights
29th Apr 20264:11 pmRNSHolding(s) in Company
21st Apr 20262:38 pmRNSDirector/PDMR Shareholding
21st Apr 20267:03 amRNSAppointment of Chief Financial Officer
17th Apr 202611:00 amRNSDirector/PDMR Shareholding
10th Apr 20263:00 pmRNSDirector/PDMR Shareholding
1st Apr 20269:04 amRNSTotal Voting Rights
25th Mar 20269:16 amRNSNotice of AGM
24th Mar 20262:17 pmRNSHolding(s) in Company
17th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20263:15 pmRNSHolding(s) in Company
6th Mar 20263:00 pmRNSHolding(s) in Company
5th Mar 20267:01 amRNSAppointment of Non-Executive Director
5th Mar 20267:00 amRNSResults for the year ended 31 December 2025
2nd Mar 202610:02 amRNSTotal Voting Rights
25th Feb 202610:00 amRNSHolding(s) in Company
2nd Feb 20264:21 pmRNSTotal Voting Rights
22nd Jan 20268:55 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
12th Jan 20262:51 pmRNSHolding(s) in Company
2nd Jan 202610:00 amRNSBlock listing Six Monthly Return
11th Dec 20253:00 pmRNSHolding(s) in Company
13th Nov 20252:00 pmRNSRefinancing of £125m revolving credit facility
10th Oct 20257:00 amRNSThird Quarter Trading Update
2nd Oct 202510:00 amRNSDirectorate Change
1st Oct 20258:04 amRNSTotal Voting Rights
26th Sep 20252:30 pmRNSHolding(s) in Company
16th Sep 20252:00 pmRNSDirector/PDMR Shareholding
29th Aug 20253:30 pmRNSHolding(s) in Company
29th Aug 202510:00 amRNSHolding(s) in Company
22nd Aug 202512:21 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSInterim Results
30th Jul 20252:00 pmRNSHolding(s) in Company
18th Jul 202511:00 amRNSHolding(s) in Company
15th Jul 20257:00 amRNSNotice of Results
10th Jul 20259:30 amRNSHolding(s) in Company
4th Jul 20259:30 amRNSHolding(s) in Company
3rd Jul 20253:00 pmRNSBlock listing Interim Review
3rd Jul 202512:00 pmRNSTotal Voting Rights
3rd Jul 20259:30 amRNSHolding(s) in Company
23rd Jun 20258:26 amRNSReport on Payments to Govts
20th Jun 202512:31 pmRNSDirector/PDMR Shareholding
12th Jun 20253:00 pmRNSHolding(s) in Company
12th Jun 20252:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.